Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Industry News

Positive Five-Year Data Published for MiStent in EuroIntervention

January 12, 2018

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

News Daily News

新型生物可吸收聚合物 SES 的良好结局持续 2 年

Yael L. Maxwell

October 02, 2015

News Daily News

Los Buenos Resultados de un Nuevo SLF de Polímero Bioabsorbibe se Mantienen a los 2 Años

Yael L. Maxwell

October 02, 2015

News Daily News

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

Yael L. Maxwell

October 02, 2015

News Daily News

ZEUS发布：在“不确定”DES候选者中，带个性化DAPT的ZES胜过裸金属支架

L.A. McKeown

February 25, 2015

News Daily News

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

L.A. McKeown

February 25, 2015

News Daily News

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

L.A. McKeown

February 25, 2015

News Daily News

SORT OUT III亚组研究揭示了DES疗效随糖尿病状态的变化

Todd Neale

November 17, 2014

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

News Daily News

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Todd Neale

November 17, 2014

Presentation ACC 2014

The Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS)

Presenter: M. Valgimigli

March 31, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Daily News

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Jason Kahn

January 22, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

September 19, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

Advertisement

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Positive Five-Year Data Published for MiStent in EuroIntervention

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

新型生物可吸收聚合物 SES 的良好结局持续 2 年

Los Buenos Resultados de un Nuevo SLF de Polímero Bioabsorbibe se Mantienen a los 2 Años

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

ZEUS发布：在“不确定”DES候选者中，带个性化DAPT的ZES胜过裸金属支架

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

SORT OUT III亚组研究揭示了DES疗效随糖尿病状态的变化

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

The Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS)

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

Studies Support DES Use in Diabetics, But Results Vary by Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content